Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Dosing: Infants and Children

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...

Pedigree Analysis

Pedigree Analysis

Nature and Nurture

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...

Probability Laws

Probability Laws

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Psoriatic arthritis spectrum in children: a multicentre observational study.

Clinical and experimental rheumatology·2026

Same author

"Adnexotropic" lichen striatus: a potential histological mimicker of mycosis fungoides.

Pathologica·2026

Same author

Systemic Sclerosis Without Raynaud Phenomenon in Children: The Fibrotic Subtype.

The Journal of rheumatology·2026

Same author

Nailfold videocapillaroscopy in the assessment of juvenile connective tissue diseases.

Clinical and experimental rheumatology·2026

Same author

Recurrent calf myositis as revealing manifestation of Crohn disease: a case report.

Frontiers in pediatrics·2026

Same author

Milk of calcium in scleromyositis.

Rheumatology (Oxford, England)·2025

Same journal

The young adult with Juvenile Idiopathic Arthritis (JIA): A clinical review of transition, complications, and psychosocial management.

Best practice & research. Clinical rheumatology·2026

Same journal

Impact of fatigue on rheumatic diseases: Current perspectives.

Best practice & research. Clinical rheumatology·2026

Same journal

Pneumocystis prophylaxis in rheumatic disease.

Best practice & research. Clinical rheumatology·2026

Same journal

Cutaneous manifestations in myositis syndromes.

Best practice & research. Clinical rheumatology·2026

Same journal

Systemic sclerosis: A comprehensive systematic review of global epidemiology, sex and ethnic disparities, disease burden, and organ-specific involvement.

Best practice & research. Clinical rheumatology·2026

Same journal

Alopecia across the spectrum of rheumatic disease.

Best practice & research. Clinical rheumatology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Feb 10, 2026

Assessing Working Memory in Children: The Comprehensive Assessment Battery for Children – Working Memory (CABC-WM)

Assessing Working Memory in Children: The Comprehensive Assessment Battery for Children – Working Memory (CABC-WM)

Published on: June 12, 2017

Scleroderma in children.

Francesco Zulian¹

¹Division of Pediatric Rheumatology, Department of Woman and Child Health, University of Padua, Padua, Italy.

Best Practice & Research. Clinical Rheumatology

|May 19, 2018

Summary

This summary is machine-generated.

Juvenile scleroderma, a common childhood rheumatic disease, sees advancements in classification and monitoring. New tools like the J4S score and improved assessment systems aid in managing juvenile localized scleroderma and systemic sclerosis.

Keywords:

Assessment Classification Juvenile localized scleroderma Juvenile systemic sclerosis Monitoring Outcome Outcome measures Severity score Treatment

More Related Videos

Eye Tracking Young Children with Autism

Eye Tracking Young Children with Autism

Published on: March 27, 2012

Studying Brain Function in Children Using Magnetoencephalography

Studying Brain Function in Children Using Magnetoencephalography

Published on: April 8, 2019

Related Experiment Videos

Last Updated: Feb 10, 2026

Assessing Working Memory in Children: The Comprehensive Assessment Battery for Children – Working Memory (CABC-WM)

Assessing Working Memory in Children: The Comprehensive Assessment Battery for Children – Working Memory (CABC-WM)

Published on: June 12, 2017

Eye Tracking Young Children with Autism

Eye Tracking Young Children with Autism

Published on: March 27, 2012

Studying Brain Function in Children Using Magnetoencephalography

Studying Brain Function in Children Using Magnetoencephalography

Published on: April 8, 2019

Area of Science:

Pediatric Rheumatology
Dermatology
Immunology

Background:

Juvenile scleroderma is the third most common rheumatic disease in children.
Recent advancements focus on classification and monitoring for juvenile systemic sclerosis (SSc) and localized scleroderma.
Existing pediatric classification criteria for SSc require enhancement.

Purpose of the Study:

To review recent developments in the classification and monitoring of juvenile scleroderma.
To discuss improvements in pediatric SSc classification criteria.
To highlight advancements in assessing and managing localized scleroderma.

Main Methods:

Review of recent literature and clinical practice guidelines.
Analysis of new classification criteria for adult SSc and their adaptation for pediatric use.
Evaluation of multidimensional severity scores like J4S for juvenile SSc.
Assessment of scoring systems for localized scleroderma.
Consideration of multicenter consensus statements and follow-up studies.

Main Results:

New classification criteria for adult SSc are influencing pediatric criteria development.
The J4S multidimensional severity score aids in daily patient management for juvenile SSc.
Clinical and instrumental scoring systems have enhanced assessment and monitoring of localized scleroderma.
Methotrexate is confirmed as a key treatment for localized scleroderma based on consensus and follow-up data.

Conclusions:

Ongoing research is refining the classification and monitoring of juvenile scleroderma.
The J4S score and improved assessment tools enhance clinical decision-making.
Evidence supports the continued use of methotrexate in treating localized scleroderma.